Postprandial Lipemia in Hypertension

REFERENCES

• Patsch JR, Miesenbock G, Hopferwieser T, Muhlberger V, Knapp E, Dunn JK, Gotto Jr AM, Pasch W: Relation of triglyceride metabolism and coronary artery disease. Studies in the postprandial state.Atherioscl Thromb12 :1336– 1345,1992 .
   PubMed Web of Science ®Google Scholar
• Przybycien K, Kornacewicz-Jach Z, Torbus-Lisiecka B, Naruszewicz M: Is abnormal postprandial lipemia a familial risk factor for coronary artery disease in individuals with normal fasting concentrations of triglycerides and cholesterol?Coronary Artery Dis11 :377– 381,2000 .
   PubMedGoogle Scholar
• Hamsten A, Bjorkengren J, Boquist S, Nilsson L, Ruotolo G, Eriksson P, Silveira A, Karpe F: Postprandial lipaemia and coronary heart disease. Jacotot B, Mathé D, Fruchart J-C (eds):“Atherosclerosis XI.” New York: Elsevier Science, pp141– 149,1998 .
   Google Scholar
• Hennig B, Toborek M, McClain CJ: High-energy diet, fatty acids and endothelial cell function: implications for atherosclerosis.J Am Coll Nutr20 :97– 105,2001 .
   PubMed Web of Science ®Google Scholar
• Oliver MF, Davies MJ: The atheromatous lipid core.Eur Heart J19 :16– 18,1998 .
   PubMed Web of Science ®Google Scholar
• Zilveresmit D: Atherogenesis: A postprandial phenomenon.Circulation60 :473– 484,1979 .
   PubMed Web of Science ®Google Scholar
• University College London Medical School: Hypertriglyceridaemia and vascular risk. Report of a meeting of physicians and scientists.Lancet342 :781– 787,1993 .
   PubMed Web of Science ®Google Scholar
• Funada J, Sekiya M, Hamada M, Hiwada K: Postprandial elevation of remnant lipoprotein leads to endothelial dysfunction.Circ J66 :127– 132,2002 .
   PubMed Web of Science ®Google Scholar
• Jagla A, Schrezenmeir J: Postprandial triglycerides and endothelial function.Exp Clin Endocrinol Diabetes109 :S533– 547,2001 .
   PubMed Web of Science ®Google Scholar
• Gokce N, Duffy SJ, Hunter LM, Keaney JF, Vita JA: Acute hypertriglyceridemia is associated with peripheral vasodilation and increased basal flow in healthy young adults.Am J Cardiol88 :153– 159,2001 .
   PubMedGoogle Scholar
• Bae JH, Bassenge E, Kim YN, Kim KS, Lee HJ, Moon KC, Lee MS, Pa KY, Schwemmer M: Postprandial hypertriglyceridemia impairs endothelial function by enhanceoxidant stress.Atherosclerosis155 :517– 523,2001 .
   PubMed Web of Science ®Google Scholar
• Lamarche B, Tchernof A, Moorjani S, Cantin B, Dagenais GR, Lupien PJ, Despres JP: Small, dense low-density lipoprotein particles as a predictor of the risk of ischemic heart disease in men. Prospective results from the Quebec Cardiovascular Study.Circulation95 :69– 75,1997 .
   PubMed Web of Science ®Google Scholar
• Griffin BA, Freeman DJ, Tait GW, Thomsson, Caslake MJ, Packard CJ, Shepherd J: Role of plasma triglyceride in the regulation of plasma low density lipoprotein (LDL) subfractions: relative contribution of small, dense LDL to coronary heart disease risk.Atherosclerosis,106 :241– 253,1994 .
   PubMed Web of Science ®Google Scholar
• Kondo A, Muranaka Y, Ohta I, Notsu K, Manabe M, Kotani K, Saito K, Maek M, Kanno T: Relationship between triglyceride concentrations and LDL size evaluated by malondialdehyde-modified LDL.Clin Chem47 :893– 900,2001 .
   PubMed Web of Science ®Google Scholar
• Malloy MJ, Kane JP: A risk factor for atherosclerosis: triglyceride-rich lipoproteins.Adv Intern Med47 :111– 136,2001 .
   PubMedGoogle Scholar
• Miller M: Differentiating the effects of raising low levels of high-density lipoprotein cholesterol versus lowering normal triglycerides: further insights from the Veterans Affairs High-Density Lipoprotein Intervention Trial.Am J Cardiol86(Suppl) :23L– 27L,2000 .
   Google Scholar
• Jastrzebska M, Przybycien K, Chelstowski K, Torbus-Lisiecka B, Kornacewicz-Jach Z, Naruszewicz M: Increased levels of factor VII, fibrinogen and activity of plasminogen activator inhibitor during postprandial triglyceridemia in patients with ischemic disease confirmed by angiography.Nutr Metab Cardiovasc Dis9 :33– 40,1999 .
   Google Scholar
• Sanders TA, Oakley FR, Cooper JA, Miller GJ: Influence of a stearic acid-rich structured triacylglycerol on postprandial lipemia, factor VII concentrations, and fibrinolytic activity in healthy subjects.Am J Clin Nutr73 :715– 721,2001 .
   PubMed Web of Science ®Google Scholar
• Collins T, Cybulsky MI: NF-kB: pivotal mediator or innocent bystander in atherogenesis?J Clin Invest107 :255– 264,2001 .
   PubMed Web of Science ®Google Scholar
• Collins R, Peto R, MacMahon S, Hebert P, Fiebach NH, Eberlein KA, Godwin J, Qizibash N, Taylor JO, Hennekens CH: Blood pressure, stroke, and coronary heart disease, II: short-term reductions in blood pressure: overview of randomised drug trials in their epidemiological context.Lancet335 :827– 838,1990 .
   PubMed Web of Science ®Google Scholar
• von Eckardstein A, Schulte H, Assmann G: Risk for diabetes mellitus in middle-aged Caucasian male participants of the PROCAM study: implications for the definition of impaired fasting glucose by the American Diabetes Association. Prospective Cardiovascular Munster.J Clin Endocrinol Metab85 :3101– 3108,2000 .
   PubMed Web of Science ®Google Scholar
• Guida L, Celentano A, Iannuzzi R, Ferrara LA: Insulin resistance ventricular mass and function in normoglycaemic hypertensives.Nutr Metab Cardiovasc Dis11 :306– 311,2001 .
   PubMed Web of Science ®Google Scholar
• Scheen AJ: The insulin sensitivity concept.Diab Metab27 :193– 200,2001 .
   PubMedGoogle Scholar
• Daubresse JC: The importance of syndrome X in daily practice.Rev Med Brux21 :473– 477,2000 .
   PubMedGoogle Scholar
• Suzuki M, Kimura Y, Tsushima M, Harano Y: Association of insulin resistance with salt sensitivity and nocturnal fall of blood pressure.Hypertension35 :864– 868,2000 .
   PubMed Web of Science ®Google Scholar
• Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RL: Homeostasis model assessment: insulin resistance and B cell function from fasting plasma glucose and insulin concentration in man.Diabetologia28 :412– 419,1985 .
   PubMed Web of Science ®Google Scholar
• Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults: Executive summary of “The Third Report of The National Cholesterol Educational Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III).”JAMA285 :2486– 2497,2001 .
   PubMed Web of Science ®Google Scholar
• Katz A, Nambi SS, Mather K, Baron AD, Follmann DA, Sillivan G, Quon MJ: Quantitative insulin sensitivity check index: a simple, accurate method for assessing insulin sensitivity in humans.J Clin Endocrinol Metab85 :2402– 2410,2000 .
   PubMed Web of Science ®Google Scholar
• Haffner SM, Mykkanen L, Festa A, Burke JP, Stern MP: Insulin-resistant prediabetic subjects have more atherogenic risk factors than insulin-sensitive prediabetic subjects. Implications for preventing coronary heart disease during the prediabetic state.Circulation101 :975– 980,2000 .
   PubMed Web of Science ®Google Scholar
• Kashiwabara H, Inaba M, Maruno Y, Morita T, Awata T, Negishi K, Iitaka M, Katayam S: Insulin levels during fasting and the glucose tolerance test and HOMA’s index predict subsequent development of hypertension.J Hypertens18 :83– 88,2000 .
   PubMedGoogle Scholar
• Taniguchi A, Fukushima M, Sakai M, Kataoka K, Nagata I, Doi K, Arakawa H, Nagasa S, Tkuyama K, Nakai Y: The role of the body mass index and triglyceride levels in identifying insulin-sensitivity and insulin-resistant variants in Japanese non-insulin-dependent diabetic patients.Metabolism49 :1001– 1005,2000 .
   PubMed Web of Science ®Google Scholar
• Gotto AM: Triglyceride as a risk factor for coronary artery disease.Am J Cardiol82 :22Q– 25Q,1998 .
   PubMed Web of Science ®Google Scholar
• Clifton PM: Postprandial lipoproteins and coronary heart disease.J Cardiovasc Risk1 :197– 201,1994 .
   PubMedGoogle Scholar
• Halkes CJ, van Dijk H, de Jaegere PP, Plokker HW, van Der Helm Y, Erkelens DW, Castro Cabezas M: Postprandial increase of complement component 3 in normolipidemic patients with coronary artery disease: effects of expanded-dose simvastatin.Arterioscler Thromb Vasc Biol21 :1526– 1530,2001 .
   PubMed Web of Science ®Google Scholar
• Parks EJ: Recent findings in the study of postprandial lipemia.Curr Atheroscler Rep3 :462– 470,2001 .
   PubMedGoogle Scholar
• Helgeland A: Treatment of mild hypertension: A five year controlled drug trial. The Oslo study.Am J Med69 :725– 732,1980 .
   PubMed Web of Science ®Google Scholar
• Samuelson O, Wilhelmen L, Andersson O, Pennert K, Berglund G: Cardiovascular morbidity in relation to change in blood pressure and serum cholesterol values in treated hypertension. Results from the primary prevention trial in Göteborg, Sweden.JAMA258 :1768– 1776,1987 .
   PubMed Web of Science ®Google Scholar
• Sharrett AR, Chambless LE, Heiss G, Paton CC, Patsch W, for the ARIC Investigators: Association of postprandial TG and retinyl palmitate responses with asymptomatic carotid artery atherosclerosis in middle-aged men and women: The Atherosclerosis Risk in Communities (ARIC) Study.Arterioscler Thromb Vasc Biol15 :2122– 2129,1995 .
   PubMed Web of Science ®Google Scholar
• Karpe F, Boquist S, Tang R, Bond GM, de Faire U, Hamsten A: Remnant lipoproteins are related to intima-media thickness of the carotid artery independently of LDL cholesterol and plasma triglycerides.J Lipid Res42 :17– 21,2001 .
   PubMed Web of Science ®Google Scholar
• Csanyi A, Egervari A, Nagy Z: Influence of hypertension and smoking as the single vascular risk factors for the intima-media thickness.Eur J Epidemiol17 :855– 861,2001 .
   PubMedGoogle Scholar
• Schillaci G, Vaudo G, Marchesi S, Lupattelli G, Reboldi G, Verdecchia P, Pasqualini L, Mannerino E: Optimizing assessment of carotid and femoral intima-media thickness in essential hypertension.Am J Hypertens14 :1025– 1031,2001 .
   PubMedGoogle Scholar
• Zizek B, Poredos P: Dependence of morphological changes of the carotid arteries on essential hypertension and accompanying risk factors.Int Angiol21 :70– 77,2002 .
   PubMedGoogle Scholar
• Bokemark L, Wikstrand J, Attvall S, Hulthe J, Wedel H, Fagerberg B: Insuline resistance and intima-media thickness in the carotid and femoral arteries of clinically healthy 58-year-old men. The Atherosclerosis and Insulin Resistance Study (AIR).J Intern Med249 :59– 67,2001 .
   PubMed Web of Science ®Google Scholar
• DeFronzo RA, Tobin J, Andres R: Glucose clamp technique: a method for quantifying insulin secretion and resistance.Am J Physiol237 :E214– 223,1979 .
   PubMed Web of Science ®Google Scholar
• Temple RC, Carrington CA, Luzia SD: Insulin deficiency in non-insulin-dependent diabetes.Lancet5 :293– 295,1989 .
   Google Scholar
• Bonora E, Targher G, Alberiche M, Bonadonna RC, Saggiani F, Zenere MB, Monauni T, Muggeo M: Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity.Diabetes Care23 :57– 63,2000 .
   PubMed Web of Science ®Google Scholar
• Mather KJ, Verma S, Anderson TJ: Improved endothelial function with metformin in type 2 Diabetes Mellitus.J Am Coll Cardiol37 :1344– 1350,2001 .
   PubMed Web of Science ®Google Scholar
• Lansing MC, Williams GH, Carroll JS: Correlation between the glucose clamp technique and the homeostasis model assessment in hypertension.Am J Hypertens14 :51– 53,2001 .
   PubMed Web of Science ®Google Scholar
• Hrebicek J, Janout V, Malincikova J, Horakova D, Cizek L: Detection of insulin resistance by simple quantitative insuline sensitivity chek index QUICKI for epidemiological assessment and prevention.J Clin Endocrinol Metab87 :144– 147,2002 .
   PubMed Web of Science ®Google Scholar
• Abbasi F, Reaven GM: Evaluation of the quantitative insulin sensitivity check index as an estimation of insulin sensitivity in humans.Metabolism51 :235– 237,2002 .
   PubMed Web of Science ®Google Scholar
• Kolovou G, Adamopoulou E, Kafaltis N, Hatzaki A, Valaora A: Essential hypertension is associated with an abnormal TG response after fat loading.Circulation98 (Suppl 1) :860 ,1998 .
   Google Scholar
• Iaina A, Silverberg DS, Wollman Y, Judevics R, Baruch R, Levhar C, Peer G, Blum M, Grosskopf I, Weintraub MS: Postprandial intestinal-derived chylomicron and chylomicron remnants in essential hypertensive patients before and after prolonged captopril therapy.Am J Hypertens8 :34– 39,1995 .
   PubMed Web of Science ®Google Scholar
• Sharrett AR, Heiss G, Chambless LE, Boerwinkle E, Coady SA, Folsom AR, Patsch W: Metabolic and lifestyle determinants of postprandial lipemia differ from those of fasting triglycerides: The Atherosclerosis Risc In Communities (ARIC) study.Aterioscler Thromb Vasc Biol21 :275– 281,2001 .
   PubMedGoogle Scholar
• Herd SL, Kiens B, Boobis LH, Hardman AE: Moderate exercise, postprandial lipemia, and skeletal muscle lipoprotein lipase activity.Metabolism50 :756– 762,2001 .
   PubMed Web of Science ®Google Scholar
• Cassader M, Gambino R, Musso G, Depetris N, Mecca F, Cavallo-Perin P, Pacini G, Rizzetto M, Pagano G: Postprandial triglyceride-rich lipoprotein metabolism and insulin sensitivity in nonalcoholic steatohepatitis patients.Lipids36 :1117– 1124,2001 .
   PubMed Web of Science ®Google Scholar
• Mamo JC, Watts GF, Barrett PH, Smith D, James AP, Pal S: Postprandial dyslipidemia in men with visceral obesity: an effect of reduced LDL receptor expression?Am J Physiol Endocrinol Metab281 :E626– E632,2001 .
   PubMedGoogle Scholar
• Beck-Nielsen H: Insulin resistance: organ manifestations and cellular mechanisms.Ugeskr Laeger164 :2130– 2135,2002 .
   PubMedGoogle Scholar
• Scherrer U, Randin D, Vollenweider P, Vollenweider L, Nicod P: Nitric oxide release accounts for insulin’s vascular effects in humans.J Clin Invest94 :2511– 2515,1994 .
   PubMed Web of Science ®Google Scholar
• Steinberg HO, Brechtel G, Johnson A, Fineberg N, Baron AD: Insulin-mediated skeletal muscle vasodilatation is nitric oxide dependent: a novel action of insulin to increase nitric oxide release.J Clin Invest94 :1172– 1179,1994 .
   PubMed Web of Science ®Google Scholar
• Forte P, Copland M, Smith LM, Milne E, Sutherland J, Benjamin N: Basal nitric oxide synthesis in essential hypertension.Lancet349 :837– 842,1997 .
   PubMed Web of Science ®Google Scholar
• Duplai H, Burcelin R, Sartori C, Cook S, Egli M, Lepori M, Vollenweider P, Pedrazzini T, Nicod P, Thorens B, Scherrer U: Insulin resistance, hyperlipidemia, and hypertension in mice lacking endothelial nitric oxide synthase.Circulation104 :342– 345,2001 .
   PubMed Web of Science ®Google Scholar
• Chen W, Srinivasan SR, Elkasabany A, Ellsworth DL, Boerwinkle E, Berenso GS: Combined effects of endothelial nitric oxide synthase gene polymorphism (G894T) and insulin resistance in young adults: the Bogalusa Heart Study.Am J Hypertens14 :1046– 1052,2001 .
   PubMed Web of Science ®Google Scholar
• Dequattro V, Feng M: The sympathetic nervous system: the muse of primary hypertension.J Hum Hypertens16(Suppl 1) :S64– S69,2002 .
   PubMedGoogle Scholar
• Ooi TC, Cousins M, Ooi DS, Steiner G, Uffelman KD, Nakajima K, Simo IE: Postprandial remnant-like lipoproteins in hypertriglyceridemia.J Clin Endocrinol Metab86 :3134– 3142,2001 .
   PubMedGoogle Scholar
• Ordovas JM: Genetics, postprandial lipemia and obesity.Nutr Metab Cardiovasc Dis11 :118– 133,2001 .
   PubMedGoogle Scholar
• Levy E, Menard D, Delvin E, Stan S, Mitchell G, Lambert M, Ziv E, Feoli-Fonseca JC, Seidman E: The polymorphism at codon 54 of the FABP2 gene increases fat absorption in human intestinal explants.J Biol Chem276 :39679– 39684,2001 .
   PubMed Web of Science ®Google Scholar